Treosulfan or busulfan plus fludarabine as conditioning treatment before allogeneic haemopoietic stem cell transplantation for older patients with acute myeloid leukaemia or myelodysplastic syndrome (MC-FludT.14/L): a randomised, non-inferiority, phase 3 trial

Publication | Open Access

DOI Full Paper Access

147

Citations

References

2019

Year

Dietrich W. Beelen, Rudolf Trenschel, Matthias Stelljes, Christoph Groth, Tamás Masszi, Péter Reményi, Eva Wagner-Drouet, Beate Hauptrock, Peter Dreger, Thomas Luft,

The Lancet Haematology

Abstract

References